ImageneBio, Inc. (IMA) Stock Analysis

ImageneBio, Inc. (IMA) is a publicly traded company in the HEALTHCARE sector. It trades at $5.47, carries a market capitalization of $66.32M. This page summarizes the public market data, fundamentals, and frequently asked questions for IMA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.47
• Market Cap: $66.32M
• EPS: $-4.78
• 52-Week High: $18.00
• 52-Week Low: $3.94

Market Sentiment

ImageneBio, Inc. currently has a Neutral sentiment score of 0.01.

About ImageneBio, Inc.

ImageneBio, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, specializing in the development of innovative therapeutics for immunological and inflammatory diseases. The firm is dedicated to addressing significant unmet medical needs by utilizing advanced research and technology to create a robust product pipeline. Focused on transforming patient care, ImageneBio aims to deliver targeted treatment solutions that enhance therapeutic efficacy and improve cli...

GNG Research Analysis

GNG Research scores ImageneBio, Inc. (IMA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IMA.

Frequently Asked Questions

Does IMA pay dividends?

ImageneBio, Inc. (IMA) does not currently pay a regular dividend.

What is IMA's market cap?

ImageneBio, Inc. (IMA) has a market capitalization of $66.32M with a current stock price of $5.47.